Dataset linking women's maternity care experiences with hospital environment and governance in Ireland.

Many scholars argue that there is a deepening crisis of trust in healthcare systems. What is not contested is the centrality of public trust in building reputational value in healthcare organisations. However, there is a dearth of research focused on better understanding how trust in healthcare institutions, and the healthcare workforce, can be sustainably cultivated.

System-wide analysis of qualitative hospital incident data: Feasibility of semi-automated content analysis to uncover insights.

Background: Advances in technology have increased the ease of reporting hospital incidents, resulting in large amounts of qualitative descriptive data. Health services have little experience analysing these data at scale to incorporate into routine reporting.

Objective: We aimed to explore the feasibility of applying a semi-automated content analysis (SACA) tool (Leximancer™) to qualitative descriptions of system-wide hospital incidents to provide insights into safety issues at all health service levels.

Chemical mixtures of mercury, PCBs, PFAS, and pesticides in freshwater fish in the US and the risks they pose for fish consumption.

Background: Freshwater fish are important food sources that also pose risks to human and wildlife health because of the bioaccumulation of environmental chemicals in their tissues. Although most studies, fish consumption advisories, and regulations focus on individual contaminants, fish consumers are exposed to mixtures of chemicals, including legacy contaminants and contaminants of emerging concern, that can have combined effects. Chemicals of emerging concern represent one source of hazard, but legacy contaminants can still pose threats to fish consumers due to their persistence in the environment.

Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B.

Small-molecule-induced protein degradation has emerged as a promising pharmacological modality for inactivating disease-relevant protein kinases. DYRK1A and DYRK1B are closely related protein kinases that are involved in pathological processes such as neurodegeneration, cancer development, and adaptive immune homeostasis. Herein, we report the development of the first DYRK1 proteolysis targeting chimeras (PROTACs) that combine a new ATP-competitive DYRK1 inhibitor with ligands for the E3 ubiquitin ligase component cereblon (CRBN) to induce ubiquitination and subsequent proteasomal degradation of DYRK1A and DYRK1B.